15 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
identified Aon’s general reputation in the industry. The Compensation Committee requested that Aon:
evaluate the efficacy of the Company’s existing
DEF 14A
9mi3d5yxq
27 Apr 22
Definitive proxy
5:03pm
10-K
di4 95mjevmpj2g
28 Mar 22
Annual report
4:51pm
10-Q
lo0krhidkkxhsprr7sa
16 Aug 21
Quarterly report
4:51pm
424B4
5z2i mkj4
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
wfmoq4u4jhfw6vb9ip
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.5
xpnnd9mx7bux
9 Jun 21
IPO registration
5:02pm
S-1
v05jxdq8ls5i yl
9 Jun 21
IPO registration
5:02pm
DRS/A
0j9icpsfoglpyxthff1
14 May 21
Draft registration statement (amended)
12:00am
DRS
ebrh5j
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next